MTIP AG

Dossier provides cloud-based competency assurance and management software for health systems worldwide, serving more than 500,000 healthcare workers. The platform supports competency modeling, embedded checklists, and the creation and assignment of competence plans, along with an employee competence portal and learning-focused portals, plus drill-down reporting and real-time analytics to help health systems measure, manage, and improve workforce capabilities, compliance, and performance.

Caresyntax develops a digital surgery platform that improves patient outcomes by analyzing large volumes of data from operating rooms. Its proprietary software and AI enable OR teams to predict and enhance surgical performance, helping surgeons benchmark their care, hospital administrators optimize resources, medical device companies advance products, and insurance providers assess risk.

Hexarad is a technology-driven teleradiology company that specializes in the remote reporting of medical scans, including CTs, MRIs, and X-rays. The company's healthcare technology platform is designed to deliver diagnostic services efficiently while prioritizing patient-centric care. It integrates image analysis algorithms to interpret medical images and optimizes workflows for scheduling, assignment, prioritization, and tracking case progress. Additionally, Hexarad offers telemedicine features that facilitate remote consultations, enabling radiologists to reduce turnaround times for diagnostic reports. This leads to faster treatment decisions and improved patient outcomes.

Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.

Apricity is the world's first virtual fertility clinic, designed to enhance the fertility treatment experience for women and couples facing challenges in conception. By integrating data and artificial intelligence, Apricity seeks to improve the chances of pregnancy success while providing a patient-centric approach. The company combines advanced technology with personalized care, offering at-home services and virtual appointments to streamline the treatment process. Led by a team of experienced entrepreneurs, medical professionals, and data scientists, Apricity aims to disrupt traditional fertility care by making it more accessible and efficient for patients.

LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-powered data platform that collects, analyzes, and interprets both structured and unstructured data from diverse sources. This platform, designed for hospitals and clinics, empowers medical professionals with actionable insights, enabling them to enhance clinical efficiency and improve the quality of patient care.

Mediktor is a developer of an advanced pre-diagnosis tool that utilizes artificial intelligence and natural language recognition to facilitate accurate symptom checking, triage, and decision-making support. The system is clinically validated and aims to transform healthcare by reducing access barriers for patients. It allows individuals to make informed decisions based on their initial symptoms while enabling healthcare providers to efficiently manage demand and optimize resources. Mediktor's technology connects patients with medical professionals within health insurance networks, assisting hospitals and health systems in making safe, rapid, and cost-effective healthcare decisions.

Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Intelligencia AI is an enterprise SaaS company that specializes in applying machine learning technology to enhance clinical development strategies. The company has developed a cloud-based platform that utilizes predictive analytics to assess, quantify, and mitigate risks associated with clinical trials. By estimating the probability of success for various trial designs, Intelligencia's platform allows healthcare organizations to optimize their approaches before initiating trials. This proactive risk management not only helps to save time and resources for clinical trials but also facilitates quicker access to innovative therapies for patients.

Founded in 2018, Koa Health develops digital wellbeing and therapeutics solutions combining clinical research and advanced technologies. It offers personalized mental health support across various conditions through its platform, which includes stepped care, secure symptom tracking, prediction tools, and evidence-based activities for stress management, sleep improvement, relaxation, positive thinking, and self-confidence enhancement.

Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and previously known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. The platform enables healthcare providers to unify clinical and administrative workflows, automate tasks, and deliver measurable care, addressing the underlying systems that drive healthcare transformation. Lumeon's clientele includes some of Europe's leading healthcare providers, such as BUPA and Nuffield Health, reflecting its position as a key player in the market. The company employs over 90 professionals dedicated to enhancing patient care through effective management and analysis of healthcare pathways.

Trialbee AB is an independent software company based in Malmö, Sweden, established in 2010. It specializes in developing a software-as-a-service solution aimed at enhancing patient matching and engagement in clinical trials. The company's platform facilitates patient recruitment, enrollment, and retention by providing various services such as resource libraries, adherence reminders, and comprehensive patient journey management. Trialbee's technology enables candidates to search for clinical trials and offers pre-screening and analysis tools, thus simplifying the clinical research process. The company serves a range of clients, including pharmaceutical sponsors, contract research organizations (CROs), investigator sites, and patients, with the goal of accelerating drug development through improved recruitment accuracy and efficiency.

Founded in 2013, Oviva specializes in digital behavior change programs for managing type 2 diabetes and obesity. Their platform combines smartphone apps and learning portals, supported by dietitian-led coaching, enabling patients to improve their health remotely and reducing healthcare system costs.

Lumeon Ltd. is a digital health company based in London, United Kingdom, specializing in care pathway management solutions for the healthcare sector. Founded in 2005 and previously known as Qinec Ltd., Lumeon offers a cloud-based platform called Care Pathway Manager, which provides a comprehensive, real-time view of the patient journey from referral to outcome. The platform enables healthcare providers to unify clinical and administrative workflows, automate tasks, and deliver measurable care, addressing the underlying systems that drive healthcare transformation. Lumeon's clientele includes some of Europe's leading healthcare providers, such as BUPA and Nuffield Health, reflecting its position as a key player in the market. The company employs over 90 professionals dedicated to enhancing patient care through effective management and analysis of healthcare pathways.

Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.

Nitinotes is a medical technology company specializing in minimally invasive gastrointestinal solutions. The company has introduced the EndoZip™, an automated gastroscopic suturing system designed for gastroenterologists and surgeons. This innovative system allows for safer and simpler gastrointestinal suturing, facilitating a non-surgical approach to bariatric treatment. By mimicking laparoscopic sleeve gastrectomy, the EndoZip™ enables effective weight-loss procedures for patients classified as obese class I and II, particularly those for whom traditional bariatric surgery is not suitable. Nitinotes aims to provide a widely accessible solution for endoscopic weight-loss treatments, ultimately helping patients achieve better health outcomes through advanced medical technology.

TytoCare develops handheld devices and software that enable users to perform self-examinations, facilitating remote diagnosis by healthcare professionals. The company's tools allow examination of various body areas and diagnose common conditions. TytoCare offers solutions for consumers (TytoHome), professionals (TytoPro), and remote clinics (TytoClinic). Incorporated in 2011, the company is headquartered in Netanya, Israel with an additional office in New York.

Founded in 2015, ReActive Robotics designs, manufactures, and sells rehabilitation robots for early movement rehabilitation post neurological injury or orthopedic surgery. Its robots aid in gait rehabilitation for neurological patients and joint replacement recovery.

Blueprint Genetics Oy is a clinical genetics testing company based in Helsinki, Finland, founded in 2012. It specializes in genetic diagnostics for rare diseases using advanced Next-Generation Sequencing (NGS) technologies. The company's services cater to hospitals and research groups, offering targeted genetic tests for a wide range of hereditary conditions, including cardiovascular diseases, cancer, and various inherited disorders. Blueprint Genetics aims to enhance the accessibility and quality of genetic diagnostics by utilizing innovative sequencing methods, such as its proprietary OS-Seq technology developed at Stanford University. The firm also provides customized sequencing and bioinformatics solutions, along with tailored services for researchers and diagnostics providers. As of early 2020, Blueprint Genetics operates as a subsidiary of Quest Diagnostics Incorporated.

Founded in 2015, ReActive Robotics designs, manufactures, and sells rehabilitation robots for early movement rehabilitation post neurological injury or orthopedic surgery. Its robots aid in gait rehabilitation for neurological patients and joint replacement recovery.